BrightSpring Health Services Inc. (BTSG) stock surged 5% in pre-market trading on Thursday, following the company's impressive fourth quarter and full-year 2024 financial results, as well as an increased guidance for fiscal 2025.
For the fourth quarter ended December 31, 2024, BrightSpring reported a 28.6% year-over-year increase in net revenue to $3.05 billion, beating analysts' expectations of $3.01 billion. The company's adjusted earnings per share of $0.22 met the consensus estimate, marking a significant improvement from $0.08 in the prior-year quarter.
BrightSpring's solid performance extended to the full year, with net revenue growing 27.6% to $11.27 billion and adjusted EBITDA rising 9.3% to $588 million compared to 2023. Excluding a one-time payment in 2023, adjusted EBITDA growth stood at an impressive 15.9%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。